1-3 of 3
John Feigert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized, Placebo-Controlled, Phase I/II Trial Of The Thrombopoietin Receptor Agonist Eltrombopag In Thrombocytopenic Patients With Advanced Myelodysplastic Syndromes Or Acute Myeloid Leukemia — A Subgroup Analysis Of Patients Receiving Concomitant Anticancer Therapy

Uwe Platzbecker, MD, PhD, Raymond S.M. Wong, Amit Verma, MD, Camille N. Abboud, MD, Sergio Araujo, Tzeon-Jye Chiou, MD, John Feigert, MD, Su-Peng Yeh, MD, Katharina Götze, M.D., Norbert Claude Gorin, MD, PhD, Peter L. Greenberg, MD, Suman Kambhampati, MD, Yoo Jin Kim, MD, Je-Hwan Lee, Roger M. Lyons, MD, Marco Ruggeri, MD, Valeria Santini, MD, Gregory Cheng, Jun Ho Jang, Chien-Yuan Chen, Souria Hasan Dougherty, Frank Mannino, Yasser Mostafa Kamel, Geoffrey W. Chan, MD, Nicole L. Stone, PhD, Aristoteles Giagounidis, MD
Journal: Blood
Blood (2013) 122 (21): 5214.
https://doi.org/10.1182/blood.V122.21.5214.5214
Published: 2013
Journal Articles

Two-Year Analysis of Efficacy and Safety of Deferasirox (Exjade®) Treatment in Myelodysplastic Syndrome Patients Enrolled in the US03 Study.

Alan F. List, Maria R. Baer, David P. Steensma, Azra Raza, Jason Esposito, Noelia Martinez-Lopez, Carole Paley, John Feigert, Emmanuel C. Besa
Journal: Blood
Blood (2009) 114 (22): 3829.
https://doi.org/10.1182/blood.V114.22.3829.3829
Published: 2009
Journal Articles

Iron Chelation with Deferasirox (Exjade ® ) Improves Iron Burden in Patients with Myelodysplastic Syndromes (MDS)

Alan F List, Maria R Baer, David Steensma, Azra Raza, Jason Esposito, Jodi Virkus, Carole Paley, John Feigert, Emmanuel C Besa
Journal: Blood
Blood (2008) 112 (11): 634.
https://doi.org/10.1182/blood.V112.11.634.634
Published: 2008